• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗地亚首例BRCA1基因大片段缺失病例报告:病例报告

The first case report of a large deletion of the BRCA1 gene in Croatia: A case report.

作者信息

Musani Vesna, Sušac Ilona, Ozretić Petar, Eljuga Domagoj, Levanat Sonja

机构信息

Rudjer Boskovic Institute Eljuga Polyclinic Department for Oncoplastic and Reconstructive Surgery, University Hospital for Tumors, University Clinical Hospital Centre Sisters of Mercy, Zagreb, Croatia.

出版信息

Medicine (Baltimore). 2017 Dec;96(48):e8667. doi: 10.1097/MD.0000000000008667.

DOI:10.1097/MD.0000000000008667
PMID:29310340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5728741/
Abstract

RATIONALE

Breast cancer is one of the most common cancers in women, and it is the leading cause of cancer related deaths in Croatia. BRCA1 and BRCA2 gene mutations are the most common cause of hereditary breast cancer.

PATIENT CONCERNS

In this report we describe a Croatian patient with no apparent family history of cancer, who developed breast cancer first at 29, and again at 33.

DIAGNOSIS

Due to the early development of first breast cancer and triple negative status of the second, the attending physician suspected a hereditary aspect.

INTERVENTIONS

Patient was sent to BRCA1 genetic testing. Subsequently, her mother and sister were sent to check for the mutation found in the patient.

OUTCOMES

BRCA1 exons 4-6 deletion was determined and sequencing confirmed the deletion as NG_005905.2:g.107648_117905del10257. Mother and sister were not affected, but since there were no available family members on the fathers' side, it was not possible to determine if this was a case of de novo mutation. Until now, only in three reports with the similar mutation the exact mutation borders were determined. The mutation in this case was not the same as previously reported and was more than twice in size.

LESSONS

All large deletions should be described at the nucleotide level, so that in cases with missing family data it would be possible to deduce if the mutation is already known. If the mutation is already known, it is probably not a de novo event, since it is unlikely that the breakpoints would be exactly the same more than once.

摘要

理论依据

乳腺癌是女性最常见的癌症之一,也是克罗地亚癌症相关死亡的主要原因。BRCA1和BRCA2基因突变是遗传性乳腺癌最常见的原因。

患者情况

在本报告中,我们描述了一名没有明显癌症家族史的克罗地亚患者,她在29岁时首次患上乳腺癌,33岁时再次患病。

诊断

由于首次乳腺癌发病较早,且第二次乳腺癌为三阴性,主治医生怀疑存在遗传因素。

干预措施

患者接受了BRCA1基因检测。随后,她的母亲和妹妹也被送去检查是否存在患者身上发现的突变。

结果

确定为BRCA1基因第4至6外显子缺失,测序证实该缺失为NG_005905.2:g.107648_117905del10257。母亲和妹妹未受影响,但由于父亲一方没有在世的家庭成员,无法确定这是否为新发突变病例。到目前为止,只有三篇报告确定了类似突变的确切突变边界。本病例中的突变与先前报道的不同,且大小超过两倍。

经验教训

所有大的缺失都应在核苷酸水平上进行描述,以便在家族数据缺失的情况下,能够推断该突变是否已知。如果该突变已知,那么它很可能不是新发事件,因为断点不太可能多次完全相同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c9/5728741/aa0fdd1ad73a/medi-96-e8667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c9/5728741/cfcc33b7246d/medi-96-e8667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c9/5728741/aa0fdd1ad73a/medi-96-e8667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c9/5728741/cfcc33b7246d/medi-96-e8667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c9/5728741/aa0fdd1ad73a/medi-96-e8667-g003.jpg

相似文献

1
The first case report of a large deletion of the BRCA1 gene in Croatia: A case report.克罗地亚首例BRCA1基因大片段缺失病例报告:病例报告
Medicine (Baltimore). 2017 Dec;96(48):e8667. doi: 10.1097/MD.0000000000008667.
2
Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia.在克罗地亚的乳腺癌/卵巢癌家族中发现了三种新型 BRCA1/BRCA2 突变。
Gene. 2012 May 1;498(2):169-76. doi: 10.1016/j.gene.2012.02.010. Epub 2012 Feb 17.
3
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.BRCA1大片段基因组重排在巴基斯坦早发性和家族性乳腺癌/卵巢癌中的作用。
Breast Cancer Res Treat. 2017 Jan;161(2):191-201. doi: 10.1007/s10549-016-4044-0. Epub 2016 Nov 8.
4
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
5
Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.遗传性乳腺癌易感性:家族病史中发病年龄的意义以及BRCA1和BRCA2的作用。
Dis Markers. 1999 Oct;15(1-3):89-92. doi: 10.1155/1999/291023.
6
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.乳腺癌高危家族中BRCA1、BRCA2、CHEK2和TP53的突变谱。
JAMA. 2006 Mar 22;295(12):1379-88. doi: 10.1001/jama.295.12.1379.
7
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.对989例乳腺癌或卵巢癌患者的综合分析提供了德国人群中BRCA1和BRCA2的突变谱及频率。
Int J Cancer. 2002 Feb 1;97(4):472-80. doi: 10.1002/ijc.1626.
8
Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.BRCA1和BRCA2基因常见突变的筛查:对突尼斯乳腺癌和/或卵巢癌家族进行基因检测的意义
Bull Cancer. 2014 Nov;101(11):E36-40. doi: 10.1684/bdc.2014.2049.
9
A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer.一名中国早发性乳腺癌女性中存在一种新型 BRCA1 种系突变。
Fam Cancer. 2011 Jun;10(2):233-7. doi: 10.1007/s10689-011-9429-y.
10
Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.在捷克高危乳腺癌/卵巢癌患者的 BRCA1 和 BRCA2 基因中筛查基因组重排:BRCA1 基因中存在高比例的群体特异性改变。
Breast Cancer Res Treat. 2010 Nov;124(2):337-47. doi: 10.1007/s10549-010-0745-y. Epub 2010 Feb 5.

引用本文的文献

1
The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer.大基因组重排在 BRCA1 和 BRCA2 中对南非家族性乳腺癌的贡献。
BMC Cancer. 2020 May 6;20(1):391. doi: 10.1186/s12885-020-06917-y.

本文引用的文献

1
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations.由新发BRCA1和BRCA2突变导致的乳腺癌和卵巢癌易感性。
Oncogene. 2016 Mar 10;35(10):1324-7. doi: 10.1038/onc.2015.181. Epub 2015 Jun 1.
2
Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families.斯洛文尼亚遗传性乳腺癌和卵巢癌家族中的新型 BRCA1 和 BRCA2 致病性突变。
Int J Oncol. 2012 Nov;41(5):1619-27. doi: 10.3892/ijo.2012.1595. Epub 2012 Aug 21.
3
Clinical significance of large rearrangements in BRCA1 and BRCA2.
BRCA1 和 BRCA2 中大片段重排的临床意义。
Cancer. 2012 Nov 1;118(21):5210-6. doi: 10.1002/cncr.27556. Epub 2012 Apr 27.
4
Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia.在克罗地亚的乳腺癌/卵巢癌家族中发现了三种新型 BRCA1/BRCA2 突变。
Gene. 2012 May 1;498(2):169-76. doi: 10.1016/j.gene.2012.02.010. Epub 2012 Feb 17.
5
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.丹麦高危乳腺癌-卵巢癌家族中BRCA1和BRCA2基因的大片段重排
Breast Cancer Res Treat. 2009 May;115(2):315-23. doi: 10.1007/s10549-008-0088-0. Epub 2008 Jun 12.
6
Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.在一个西班牙乳腺癌/卵巢癌家族中鉴定出一种新型BRCA1大基因组重排。
Breast Cancer Res Treat. 2008 Nov;112(1):63-7. doi: 10.1007/s10549-007-9839-6. Epub 2007 Dec 1.
7
Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.在德裔高危家族中,BRCA1基因的大片段重排而非BRCA2基因的大片段重排在乳腺癌和卵巢癌的易感性中起显著作用。
Cancer Genet Cytogenet. 2006 Jul 1;168(1):44-9. doi: 10.1016/j.cancergencyto.2005.07.005.
8
Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations.在一大群未检测到BRCA1和BRCA2点突变的意大利乳腺癌和乳腺/卵巢癌家族中BRCA1基因重排的患病率。
Genes Chromosomes Cancer. 2006 Sep;45(9):791-7. doi: 10.1002/gcc.20342.